"Dehydroepiandrosterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
| Descriptor ID |
D003687
|
| MeSH Number(s) |
D04.210.500.054.079.429.625 D04.210.500.578.502.400 D06.472.040.502.400 D06.472.334.851.968.952
|
| Concept/Terms |
Dehydroepiandrosterone- Dehydroepiandrosterone
- 5-Androsten-3-beta-hydroxy-17-one
- 5 Androsten 3 beta hydroxy 17 one
- DHEA
- Prasterone
- Androstenolone
- Dehydroisoandrosterone
|
Below are MeSH descriptors whose meaning is more general than "Dehydroepiandrosterone".
Below are MeSH descriptors whose meaning is more specific than "Dehydroepiandrosterone".
This graph shows the total number of publications written about "Dehydroepiandrosterone" by people in this website by year, and whether "Dehydroepiandrosterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 3 | 6 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dehydroepiandrosterone" by people in Profiles.
-
Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review. Obstet Gynecol. 2023 09 01; 142(3):555-570.
-
Fetal sex and the development of gestational diabetes mellitus in polycystic ovarian syndrome gravidae. Am J Obstet Gynecol MFM. 2023 05; 5(5):100897.
-
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres. J Neurooncol. 2022 Dec; 160(3):677-689.
-
Adrenarcheal hormone-related development of white matter during late childhood. Neuroimage. 2020 12; 223:117320.
-
Relationships between adrenarcheal hormones, hippocampal volumes and depressive symptoms in children. Psychoneuroendocrinology. 2019 06; 104:55-63.
-
Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials. Clin Endocrinol (Oxf). 2019 02; 90(2):293-300.
-
Assay validation of hair androgens across the menstrual cycle. Psychoneuroendocrinology. 2019 03; 101:175-181.
-
Associations between adrenarcheal hormones, amygdala functional connectivity and anxiety symptoms in children. Psychoneuroendocrinology. 2018 11; 97:156-163.
-
Brain structural connectivity during adrenarche: Associations between hormone levels and white matter microstructure. Psychoneuroendocrinology. 2018 02; 88:70-77.
-
The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. J Ovarian Res. 2017 May 04; 10(1):32.